Scroll Top
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Our Magellan™ Platform: AI-Powered Drug Discovery
Allosteric Innovation Next-Gen Therapies
Our Research Posters on Drug Development | Gain Therapeutics
Our Peer-Reviewed Publications in Drug Discovery
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Our Magellan™ Platform: AI-Powered Drug Discovery
Allosteric Innovation Next-Gen Therapies
Our Research Posters on Drug Development | Gain Therapeutics
Our Peer-Reviewed Publications in Drug Discovery
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Our Magellan™ Platform: AI-Powered Drug Discovery
Allosteric Innovation Next-Gen Therapies
Our Research Posters on Drug Development | Gain Therapeutics
Our Peer-Reviewed Publications in Drug Discovery
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
The Future Of Inflammation: The Inflammasome And Beyond
Insights Citeline
Nov 13, 2024
The Future Of Inflammation: The Inflammasome And Beyond
Related Posts
Post navigation
Previous Post
Gene Mack, Interim CEO & CFO of Gain Therapeutics: Leading the Charge in Parkinson’s Breakthroughs
Next Post
GT-02287 seen to safely enter brain in early Parkinson’s clinical trial
Latest Articles
Clear Filters
November 20, 2024
New vodcast: Joanne Taylor, Gain Therapeutics, at Neuroscience 2024
https://www.ddw-online.com/new-vodcast-joanne-taylor-gain-therapeutics-at-neuroscience-2024-32570-202411/
Read More
November 19, 2024
GT-02287 seen to safely enter brain in early Parkinson’s clinical trial
https://parkinsonsnewstoday.com/news/gt-02287-safely-enters-brain-early-parkinsons-clinical-trial/
Read More
November 13, 2024
The Future Of Inflammation: The Inflammasome And Beyond
https://insights.citeline.com/in-vivo/market-intelligence/the-future-of-inflammation-the-inflammasome-and-beyond-JL3UJUJNGRGGNL2VCEBU2MUWEU/
Read More
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Our Magellan™ Platform: AI-Powered Drug Discovery
Allosteric Innovation Next-Gen Therapies
Our Research Posters on Drug Development | Gain Therapeutics
Our Peer-Reviewed Publications in Drug Discovery
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
